Physician profile
Melissa Bailey
NPI 1063761609
$993.06
in general payments reported to CMS, 2019-2025
9 companies · $347 in 2025
The $347 reported for 2025 was more than what a typical Orthodontics and Dentofacial Orthopedics provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $122 · 2020: $63.20 · 2021: $126 · 2022: $148 · 2023: $82.20 · 2024: $105 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Travel and Lodging: $154 · Consulting Fee: $35.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.86 |
| Travel and Lodging | $154.30 |
| Consulting Fee | $35.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Align Technology, INC. | $289.18 | 2022-2025 | Invisalign, Invisalign First - Comprehensive Phase 2, Itero |
| Straumann USA LLC | $195.96 | 2021-2025 | |
| American Orthodontics Corporation | $182.76 | 2019-2025 | Empower-Metal, Lp and Ifit Tubes, Radiance |
| Intuitive Surgical, INC. | $154.30 | 2025 | |
| Stryker Corporation | $63.20 | 2020 | |
| Lightforce Orthodontics, INC. | $59.24 | 2024 | |
| Solventum Corporation | $22.54 | 2024 | 3m Unitek Victory Series, Transbond Plus |
| 3m Company | $15.31 | 2019 | |
| USA Angelalign Technology Corp | $10.57 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Bailey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.